Tella S R, Korupolu G R, Schindler C W, Goldberg S R
Behavioral Pharmacology and Genetics Section, National Institute on Drug Abuse Addiction Research Center, Baltimore, Maryland.
J Pharmacol Exp Ther. 1992 Sep;262(3):936-46.
In conscious rats, continuous i.v. infusion of cocaine (2 mg/kg/min) produced a marked increase in blood pressure, an initial moderate increase followed by a decrease in heart rate, tonic-clonic convulsions and, finally, a lethal episode of status epilepticus. No change in rectal temperature was observed. Infusion of cocaine methiodide (2 mg/kg/min), a quaternary derivative of cocaine, also produced a lethal episode of status epilepticus, but it was 6 times less potent than cocaine on a molar basis. In pentobarbital-anesthetized, spontaneously breathing rats, cocaine produced death by respiratory failure. Artificial ventilation of pentobarbital-anesthetized rats elevated the lethal dose of cocaine by 15-fold and these animals died of marked hypotension. In conscious rats, pretreatment with dl-, d- or l-propranolol or the alpha 2-selective adrenoceptor antagonist yohimbine enhanced the convulsive and lethal effects of cocaine. In contrast, the alpha 2-selective adrenoceptor agonist clonidine or the alpha 1-selective adrenoceptor antagonist prazosin attenuated these effects. Yohimbine antagonized the protective effect of clonidine. The nonselective alpha adrenoceptor antagonist phentolamine, the autonomic ganglionic blocker chlorisondamine and various calcium channel blockers had no effect on the convulsive or lethal doses of cocaine. The pressor response to cocaine was attenuated by calcium channel blockers, clonidine, phentolamine and dl- or l-propranolol, but not by d-propranolol. The pressor response to cocaine was abolished by chlorisondamine, reversed to a depressor response by prazosin and enhanced by yohimbine. The initial tachycardiac response to cocaine was reversed to bradycardia by dl- and l-propranolol, prazosin, yohimbine or high doses of the calcium channel blockers, but was unaffected by phentolamine, d-propranolol, clonidine or chlorisondamine. These results indicate that in spontaneously breathing animals, acute i.v. infusions of lethal doses of cocaine produce death primarily by central effects, namely by status epilepticus in conscious rats and by respiratory arrest in pentobarbital-anesthetized rats. In artificially ventilated, pentobarbital-anesthetized rats, however, cocaine produces death by effects on the cardiovascular system. In conscious rats, endogenous alpha 1 adrenoceptors exert a deleterious influence on cocaine-induced convulsive and lethal effects, whereas alpha 2 adrenoceptors provide protective influence. Propranolol appears to enhance cocaine-induced acute lethality through a mechanism independent of beta adrenoceptors. Calcium channel blockers appear ineffective in antagonizing cocaine's lethality.
在清醒大鼠中,持续静脉输注可卡因(2毫克/千克/分钟)可使血压显著升高,心率起初适度增加,随后下降,出现强直性阵挛性惊厥,最终导致致死性癫痫持续状态发作。未观察到直肠温度变化。输注可卡因甲碘化物(2毫克/千克/分钟),一种可卡因的季铵衍生物,也会导致致死性癫痫持续状态发作,但按摩尔计算其效力比可卡因低6倍。在戊巴比妥麻醉、自主呼吸的大鼠中,可卡因导致呼吸衰竭死亡。对戊巴比妥麻醉的大鼠进行人工通气可使可卡因的致死剂量提高15倍,这些动物死于明显的低血压。在清醒大鼠中,用消旋、右旋或左旋普萘洛尔或α2选择性肾上腺素能受体拮抗剂育亨宾预处理可增强可卡因的惊厥和致死作用。相反,α2选择性肾上腺素能受体激动剂可乐定或α1选择性肾上腺素能受体拮抗剂哌唑嗪可减弱这些作用。育亨宾拮抗可乐定的保护作用。非选择性α肾上腺素能受体拮抗剂酚妥拉明、自主神经节阻滞剂氯异吲哚铵和各种钙通道阻滞剂对可卡因的惊厥或致死剂量无影响。钙通道阻滞剂、可乐定、酚妥拉明和消旋或左旋普萘洛尔可减弱对可卡因的升压反应,但右旋普萘洛尔无此作用。氯异吲哚铵可消除对可卡因的升压反应;哌唑嗪可使其反转成降压反应;育亨宾可增强此反应。对可卡因最初的心动过速反应可被消旋和左旋普萘洛尔、哌唑嗪、育亨宾或高剂量钙通道阻滞剂反转成心动过缓,但不受酚妥拉明、右旋普萘洛尔、可乐定或氯异吲哚铵影响。这些结果表明,在自主呼吸的动物中,急性静脉输注致死剂量可卡因主要通过中枢效应导致死亡,即在清醒大鼠中通过癫痫持续状态,在戊巴比妥麻醉的大鼠中通过呼吸骤停。然而,在人工通气、戊巴比妥麻醉的大鼠中,可卡因通过对心血管系统的作用导致死亡。在清醒大鼠中,内源性α1肾上腺素能受体对可卡因诱导的惊厥和致死作用产生有害影响,而α2肾上腺素能受体则提供保护作用。普萘洛尔似乎通过一种独立于β肾上腺素能受体的机制增强可卡因诱导的急性致死性。钙通道阻滞剂似乎无法拮抗可卡因的致死性。